Hypoglycaemia and its management Expert Group Lead Discussant A/Prof Goh Su-Yen, Endocrinology (SGH) Chairperson A/Prof Michelle Jong, Endocrinology (TTSH) Members Ms Kala Adaikan, Dietetics (SGH) Ms Debra Chan Shu Zhen, Pharmacy (TTSH) Dr Anthony Chao, Family Medicine (Boon Lay Clinic & Surgery Pte Ltd) Dr Cheah Ming Hann, Family Medicine (NUP) Dr Khoo Chin Meng, Family Medicine (NUHS) Ms Lee Hwee Khim, Nursing (SHP) Prof Joyce Lee, Pharmacy (UC Irvine) Dr Phua Eng Joo, Endocrinology (KTPH) Dr Darren Seah, Family Medicine (NHGP) Clin Asst Prof Gilbert Tan Choon Seng, Family Medicine (SHP) A/Prof Thai Ah Chuan, Endocrinology (NUH) Agency for Care Effectiveness, Ministry of Health, Republic of Singapore All rights reserved
Meals that used to be satisfying may leave you wanting more
Both age groups benefit from the medication, but their priorities and results can look very different
Clinical Evidence Supporting GLP1 MASLD MASH Treatment Several clinical trials support the use of GLP1 receptor agonists in reducing hepatic fat and improving histologic features of MASH
Below is a list of key sources that provided valuable insights and data, ensuring the credibility and reliability of the information presented
